Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 14, 2009
Tue, October 13, 2009 ARIA, MATW, TRGT, ZHNE, ARTNA, KFS Expected To Be Higher Leading Up To Next Earnings Releases
October 14, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and October/November earnings reports. ARIAD Pharmaceuticals (NASDAQ: ARIA), Matthews International (NASDAQ: MATW), Targacept (NASDAQ: TRGT), Zhone Technologies (NASDAQ: ZHNE), Artesian Resources (NASDAQ: ARTNA) and Kingsway Financial Services (NYSE: KFS) are all expected to be higher leading up to their next earnings release. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act before its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go higher leading up to their next earnings release:
Symbol Company # of Releases Quarter Release Date
ARIA ARIAD Pharmaceuticals November earnings Q3 11/5/2009
MATW Matthews International 12 quarters Q4 11/12/2009
TRGT Targacept, Inc. 12 quarters Q3 11/5/2009
ZHNE Zhone Technologies 12 quarters Q3 10/20/2009
ARTNA Artesian Resources Corp November earnings Q3 11/3/2009
KFS Kingsway Financial 12 quarters Q3 11/6/2009
Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA), a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer in the United States and Europe. Its product candidates include deforolimus, a potent mTOR inhibitor for the treatment of solid tumors, including sarcomas, hormone refractory prostate cancer, endometrial cancer, brain cancer, leukemias, and lymphomas; and AP24534, a multi-targeted kinase inhibitor for the treatment of chronic myeloid leukemia (CML), acute myeloid leukemia (AML), and other hematological cancers. ARIAD conducts Phase 3 clinical trials of oral deforolimus in patients with metastatic soft-tissue and bone sarcomas; Phase 2 clinical trials in patients with endometrial, breast, and prostate cancers; and Phase 1 studies of deforolimus in combination with other agents, as well as Phase 1 clinical trials of AP24534 in patients with refractory CML, AML, and other hematological malignancies. Its drug discovery programs are centered on small-molecule therapies, molecularly targeted to cell-signaling pathways implicated in cancer. In addition, the company licenses NF-kB cell-signaling technology and treatment methods to pharmaceutical and biotechnology companies conducting research to discover and develop drugs that modulate NF-kB cell-signaling and/or marketing such drugs; and ARGENT cell-signaling regulation technologies to pharmaceutical and biotechnology companies to develop and commercialize therapeutic products and to conduct drug discovery research. It has a collaboration agreement with Merck & Co., Inc. to develop and commercialize deforolimus; and license agreements with Medinol and ICON to develop and commercialize deforolimus-eluting stents and other medical devices to prevent restenosis, or reblockage of injured vessels following interventions, in which stents are used in conjunction with balloon angioplasty. The company was founded in 1991 and is based in Cambridge, Massachusetts.
Matthews International Corporation (NASDAQ: MATW) designs, manufactures, and markets memorialization products and brand solutions for the cemetery and funeral home industries in the United States, Mexico, Canada, Europe, Australia, and China. It operates in six segments: Bronze, Casket, Cremation, Graphics Imaging, Marking Products, and Merchandising Solutions. The Bronze segment provides cast bronze memorials and other memorialization products; cast and etched architectural products; and builds mausoleums. The Casket segment produces a range of wood and metal caskets; and casket components, such as stamped metal parts, metal locking mechanisms for gasketed metal caskets, adjustable beds, interior panels, and plastic ornamental hardware, as well as provides assortment planning and merchandising, and display products to funeral service businesses. The Cremation segment offers products and services, including cremation equipment; cremation caskets; equipment service and repair; and supplies and urns. The Graphics Imaging segmenta�s products and services include brand management, pre-press services, printing plates, gravure cylinders, steel bases, embossing tools, special purpose machinery, engineering and print process assistance, print production management, digital asset management, content management, and package design services. The Marking Products segment offers a range of marking and coding products and related consumables, and industrial automation products for identifying, tracking, and conveying consumer and industrial products, components, and packaging containers. The Merchandising Solutions segment provides merchandising displays and systems comprising permanent and temporary displays, custom store fixtures, brand concept shops, interactive kiosks, custom packaging, and screen and digitally printed promotional signage, as well as engages in design and engineering services. Matthews International was founded in 1850 and is based in Pittsburgh, Pennsylvania.
Targacept, Inc. (NASDAQ: TRGT), a biopharmaceutical company, engages in the design, discovery, and development of neuronal nicotinic receptor (NNR) Therapeutics for the treatment of diseases and disorders of the central nervous system. It markets Inversine, which is for the management of moderately severe to severe hypertension and uncomplicated cases of malignant hypertension. The companya�s clinical stage product candidates include TC-5214 in Phase 2b clinical trial that modulates the activity of various NNR subtypes, including multiple forms of the a42 NNR; AZD3480 (TC-1734), a small molecule, which modulates the activity of the a42 NNR and completed two Phase 2b clinical trials; and TC-5619, a small molecule for cognitive dysfunction in schizophrenia or conditions characterized by cognitive impairment that completed a Phase 1 single and multiple rising dose clinical trial. It also has clinical stage product candidates, such as TC-2216, a product candidate for depression and anxiety disorders that completed a Phase 1 single rising dose clinical trial; and AZD1446 (TC-6683), a small molecule in Phase 1 clinical development that modulates the activity of the a42 NNR. In addition, the company has preclinical research programs to discover and develop compounds that act on the a42 NNR; and a program focused on the role of NNRs in inflammation. It has a cognition-focused collaboration with AstraZeneca AB. The company has a strategic alliance with SmithKline Beecham Corporation and Glaxo Group Limited to discover, develop, and market product candidates that selectively target specified NNR subtypes in therapeutic focus areas, including pain, smoking cessation, addiction, obesity, and Parkinsona�s disease. Targacept, Inc. was founded in 1997 and is based in Winston-Salem, North Carolina.
Zhone Technologies, Inc. (NASDAQ: ZHNE), together with its subsidiaries, designs, develops, and manufactures communications network equipment for telephone companies and cable operators worldwide. The company offers single line multi-service (SLMS) architecture, which provides voice over Internet protocol (IP) and IP video by integrating access, transport, customer premises equipment, and management functions in a standards-based system. Its SLMS products include broadband aggregation and service products that are deployed in central offices, remote offices, points of presence, curbsides, data and co-location centers, and enterprises aggregate and optimize communications traffic from copper and fiber networks; customer premise equipment, which offer solutions for combining analog voice and data services to the subscribera�s premises over a single platform; and Zhone management system product that provides optional software tools to manage aggregation and customer premises network hardware. These products deliver voice, data, and video interface connectivity for broadcast and subscription television, Internet routers, and telephony equipment. In addition, Zhone Technologies offers products that are deployed by service providers, which support various voice and data services; and offers technical support, product repair, and education and support services. The company sells its products and services to network service providers that offer voice, data, and video services to businesses, governments, utilities, and residential consumers, as well as to telecommunications carriers. Zhone Technologies sells its products and services through channel partners, including distributors, resellers, system integrators, and service providers. The company was founded in 1999 and is headquartered in Oakland, California.
Artesian Resources Corporation (NASDAQ: ARTNA), through its subsidiaries, distributes and sells water to residential, commercial, industrial, governmental, municipal, and utility customers in Delaware, Pennsylvania, and Maryland. It also provides water for public and private fire protection to customers in its service territories. In addition, the company designs and builds water and wastewater infrastructure and provides contract water and wastewater services. As of December 31, 2008, Artesian Resources Corporation had approximately 75,800 metered customers, 632 wastewater customers, and served a population of approximately 250,000. It served customers through approximately 1,112 miles of transmission and distribution mains. The company was founded in 1905 and is headquartered in Newark, Delaware.
Kingsway Financial Services Inc. (NYSE: KFS), through its subsidiaries, provides property and casualty insurance to individuals and businesses in the United States and Canada. It primarily offers non-standard automobile and trucking insurance. The companya�s non-standard automobile insurance covers drivers who do not qualify for standard automobile insurance coverage because of their payment history, driving record, place of residence, age, vehicle type, or other factors; and trucking insurance cover liability, accident benefits, physical damage, cargo, and comprehensive general liability under a package program. It also provides standard automobile insurance; commercial automobile insurance; commercial and personal property coverages; motorcycle insurance; specialized commercial and personal property coverages; residential wind insurance coverage; construction defect claims; and other specialty coverages, such as customs, bail, and surety bonds. In addition, the company purchases reinsurance from third parties. It distributes its products through a network of independent agents and program managers in the United States, as well as through independent brokers in Canada. The company was founded in 1989 and is based in Mississauga, Canada.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
One example from the SqueezeTrigger database is approximately 2.5 billion short sale transactions going back to January 1, 2005, and SqueezeTrigger calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com
Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering!
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
